Pharma-Bio Serv Q3 revenue falls 20.5% YoY; net income boosted by $1.96M PPP forgiveness

Pharma-Bio Serv, Inc.

Revenue for Q3 $4.99M, down 20.5% YoY from $6.28M.
Net income $2.28M includes $1.96M PPP loan forgiveness; prior year $0.69M.
Nine-month revenue $14.5M vs $16.5M, down 12.2% YoY.
Company focused on M&A strategy and geographic expansion.

item 2.02 item 9.01

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-21-010086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.